Engineered to protect ventilated patients with a multi-factorial approach
The Venner PneuX™ System is associated with a very high reduction in VAP. This can potentially lead to significant cost reductions and should be implemented as part of the VAP reduction bundle.” The estimated total net savings for a hospital performing 300 episodes of intubation per year were £255,108. Return on investment (668%).
Overall, findings suggest that the benefits of Venner PneuX™ exceed its additional cost, resulting in a total net benefit of £738 per patient. Venner PneuX™ resulted in lower costs and a gain in quality-adjusted life years. The results are robust to extreme values of the key parameters in the analysis.